Remove Financial Statement Remove IPO Remove Webinar
article thumbnail

Cooley’s 2020 Life Sciences M&A Year in Review

Cooley M&A

Fortunately, in May 2020, the SEC adopted amendments to the financial disclosure requirements that alleviated some of the burden for public company buyers in those transactions by permitting the use of abbreviated financial statements without the need to seek exemptive relief, as discussed in more detail in our previous blog post.

M&A 40